Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
OVID · Sep 30, 2025
Ovid Therapeutics Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001636651-25-000012General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-9751.52% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-23.70% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-9487.12% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4446.97% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
839.39% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History10 statesHistory building
Dec 31, 20230/6 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20240/6 normalizedLevel 3Sep 30, 20240/6 normalizedLevel 3Dec 31, 20245/6 normalizedLevel 3Mar 31, 20255/6 normalizedLevel 3Jun 30, 20255/6 normalizedLevel 3Sep 30, 20255/6 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Jun 30, 20265/5 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- -76.12%
- Current
- -9751.52%
- Delta
- -9675.40%
- Previous
- 3611.24%
- Current
- -23.70%
- Delta
- -3634.94%
- Previous
- -80.88%
- Current
- -9487.12%
- Delta
- -9406.24%
- Previous
- 103.08%
- Current
- 4446.97%
- Delta
- 4343.89%
- Previous
- 19.44%
- Current
- 839.39%
- Delta
- 819.96%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · OVID Fundamental State →Has State · Ovid Therapeutics Inc. →Transitioned To · OVID Fundamental State →Transitioned To · OVID CASH_GENERATION_DECREASED →Transitioned To · OVID GROWTH_DECREASED →Transitioned To · OVID PROFITABILITY_DECREASED →Transitioned To · OVID R_AND_D_INTENSITY_INCREASED →Transitioned To · OVID SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.